Join a Legacy of Innovation 110 Years and Counting!
With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group's 2025 Vision to become a "Global Pharma Innovator with a Competitive Advantage in Oncology," Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases.
In alignment with leadership, internal teams and brand needs this position oversees and manages US Medical Affairs activities including strategy, communications, and medical affairs directed clinical activities in oncology. The position has leadership responsibility for Medical Affairs personnel working on their assigned Oncology portfolio product(s) that can range from late clinical phases through launch and post-approval. In partnership with the New Product or Commercial Brand Teams, the Medical Affairs lead develops the commercial strategy based on the scientific development and appropriate communication for the products. The position must effectively collaborate with Clinical Research and with co-promote or co-development partners to effectively guide the scientific efforts needed in support of Daiichi Sankyo brands. Additionally, the Senior Director contributes to excellence in clinical research by developing strategies for lifecycle management, IIS programs and post approval clinical programs in consultation with global, commercial, development and outside experts, and by building the image of the company as a partner in research projects.
Serve as the face of Daiichi Sankyo US Medical Affairs and support Oncology Field Medical Affairs for interactions with Key Opinion Leaders in Oncology overseeing interactions that include advisory boards, Congress activities, investigator-initiated studies, advocacy and sponsorships. Interact with investigators and members of the medical community to assist in understanding current academic, clinical trial and practice issues related to DS Oncology therapeutic strategies.
Partner with cross-functional colleagues including commercial, global medical affairs and clinical development to oversee and lead development of cross-tumor medical affairs plans, including Medical objectives, strategies and tactics leading up to launch and carrying through to later stages of commercialization.
Leadership of portfolio medical directors, associate directors, and/or managers and cross-functional collaboration across product and franchise medical affairs functions to ensure strategic, timely and appropriate implementation of scientific communication and engagement activities at major congresses, medical meetings, and other venues; ensure timely release of data supporting core development areas; assure high quality outputs as well as compliance with appropriate internal and external publication practices. Responsible for coordinating (in collaboration with stakeholders as appropriate) portfolio advisory meetings to enhance life cycle management and contribution of the Oncology portfolio to patient care and corporate presence.
Responsible for developing/informing overall medical affairs strategy for assigned product(s), including interpretation of competitive data and determining implications to the clinical landscape; Oversee the interpretation, publication/ public disclosure and interpretation of scientific data generated by studies conducted by the Oncology teams. Oversee the development of scientific content for medical communication and scientific education initiatives that occur as a result of studies conducted by the Oncology teams; Responsible for guiding therapeutic area training needs of field-based Medical Science Liaisons including the development of training materials and appropriate sessions to maintain high level of clinical expertise in the field of oncology.
Guide and develop team through mentorship, as well as effectively manage annual operating plan and budget for assigned product(s). Ensure collaboration between cross-functional stakeholders, including Global Medical Affairs, US/Global Commercial, and Clinical Development.
Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Advanced degree in the Health Sciences, such as PharmD or PhD is required; training or experience in a relevant therapeutic area is preferred. MD acceptable, but not required.
Minimum of 10 years' experience of which 7 years of experience in clinical / research / academic medicine.
Minimum of 3 years of pharmaceutical industry or development experience. Proven track record of working successfully with cross-functional internal teams as well as external stakeholders to achieve goals. Experience with oncology medical strategies and scientific research/communication plans is required. Understanding of the broader solid tumor landscape is required. Direct team leadership and management experience required.
Excellent written and oral communication skills, particularly strong formal presentation skills; strong interpersonal skills commensurate with the need to work closely with both outside physicians/ scientists and numerous in-house support groups; strong managerial skills to lead effectively and motivate staff; demonstrated high proficiency in problem solving ability and possession of strong scientific analytical skills; excellent planning and organizational skills; experience in setting and adhering to departmental budgets; knowledge of scientific methods, research design and medical practices and procedures that would be acquired through clinical experience and clinical research studies.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.